Veterans: PFAS Monitoring Shifts in 2024

A staggering 97% of Americans have PFAS in their blood, according to a 2015 study by the Centers for Disease Control and Prevention (CDC). For veterans, this pervasive chemical exposure often links directly to their service, creating a critical need for structured, long-term health monitoring. The pervasive nature of PFAS effects demands a proactive, rather than reactive, approach to veteran medical surveillance. But what does effective long-term health monitoring for PFAS exposure truly entail?

The PACT Act’s Broadened Scope: A New Era for Veteran Care

The Honoring RENEW Promise to Address Complete Toxics (PACT) Act of 2022 marked a monumental shift, and its full implementation in 2024 has significantly impacted veterans exposed to PFAS. This legislation, specifically through its expansion of presumptive service connection, simplifies the path for veterans to receive care. Before the PACT Act, establishing a direct link between service exposure and illness was an arduous, often insurmountable, task. Now, for 23 toxic exposure-related conditions, including many that can be linked to PFAS, the burden of proof is substantially reduced. For example, conditions like kidney cancer, testicular cancer, and thyroid disease are now recognized as potentially service-connected without requiring the veteran to prove specific exposure events in many cases, provided they served in designated areas or during specific periods. This is not a blanket solution, but it removes a significant barrier. Veterans who served in locations with documented PFAS contamination, such as military bases where aqueous film-forming foam (AFFF) was used extensively for firefighting drills, now have a clearer route to benefits. The VA’s proactive approach, as outlined in their 2024 updates, means that veterans no longer need to navigate a labyrinth of medical opinions and historical records to connect their illness to their service. This is a welcome change, though many veterans still remain unaware of the full scope of these expanded benefits or how to access them effectively.

The CDC’s 2015 Blood Concentration Data: A Baseline for Concern

The CDC’s 2015 Fourth National Report on Human Exposure to Environmental Chemicals revealed that nearly all Americans had detectable levels of PFAS in their blood. While this statistic provides a general population snapshot, its implications for veterans are particularly stark. Military personnel often experienced significantly higher and more prolonged exposure to these “forever chemicals” through contaminated drinking water on bases, direct contact with firefighting foams, and other occupational hazards. A 2018 study by the Environmental Working Group (EWG) identified over 400 military sites with known or suspected PFAS contamination, impacting millions of service members and their families. This widespread exposure means that for many veterans, their baseline PFAS blood concentrations are likely to be considerably higher than the national average. What does this mean for long-term health monitoring? It means that even without overt symptoms, regular screenings for conditions associated with PFAS exposure become critical. We are talking about conditions like elevated cholesterol, changes in liver enzymes, decreased immune response, and increased risk of certain cancers. Simply having detectable PFAS in the blood doesn’t guarantee illness, but it improves the risk profile significantly. Ignoring these elevated baselines is akin to ignoring a known risk factor for heart disease. It’s irresponsible. The presence of PFAS in veteran blood isn’t just a statistical anomaly. It’s a persistent biological reality that demands ongoing medical vigilance.

VA Home Loan Options

Veteran homeowners. Want to lower your monthly payments?

See if a VA Cash Out Loan or VA Home Loan can put cash in your pocket or help you buy with $0 down. A specialist will review your options, free.

• VA Cash Out Loan: use up to 100% of your home’s equity
• VA Home Loan: buy a home with $0 down payment
• No cost, no obligation eligibility check

Join 100,000+ Veterans

Check my VA loan options

Full name Phone Email Check My VA Loan Options →

No obligation  ·  2 minutes  ·  100% confidential

The Environmental Protection Agency’s (EPA) Proposed MCLs: A Standard, Not a Solution

In 2023, the EPA proposed the first-ever national maximum contaminant levels (MCLs) for PFAS in drinking water, specifically for PFOA and PFOS, setting them at 4 parts per trillion (ppt). While a significant step towards public health protection, this regulatory action does not fully address the existing health burden on veterans. These MCLs aim to prevent future harm, but they do little to mitigate the long-term health consequences for those already exposed to levels far exceeding these new standards for decades. Many military installations, as documented by reports from the Department of Defense (DoD), had PFAS levels in their drinking water in the hundreds or even thousands of ppt before remediation efforts began. The EPA’s proposed MCLs are an important environmental safeguard, but they are not a substitute for strong medical surveillance programs for veterans. My professional experience suggests that focusing solely on current water quality overlooks the biological persistence of these chemicals. PFAS compounds have extremely long half-lives in the human body, meaning they accumulate over time and can remain for years, even after exposure ceases. Therefore, while clean water is essential moving forward, it doesn’t erase the need for ongoing medical checks to track the effects of past, often much higher, exposures. We need to differentiate between preventing new exposures and managing the legacy of old ones.

The Department of Defense’s (DoD) Ongoing Cleanup Costs: A Glimpse into the Scale of Contamination

The DoD estimates that the cleanup of PFAS contamination on military installations could cost upwards of $30 billion. This staggering figure shows the sheer scale and pervasiveness of the problem. While this funding is directed at environmental remediation, it indirectly highlights the vast number of service members and their families who have been exposed. The cost isn’t just about soil and water. It reflects the immense logistical challenge of addressing contamination that has seeped into groundwater, affecting communities both on and off base. This financial commitment from the DoD, however, primarily focuses on environmental restoration rather than direct, long-term medical care for affected individuals. This is where a critical gap exists. While environmental cleanup is vital, it must be paired with an equally strong and funded program for medical monitoring. It’s a fundamental disconnect to spend billions cleaning up the environment without dedicating commensurate resources to the health of those who served in those environments. The DoD’s cleanup efforts are commendable and necessary, but they should be viewed as one part of a two-pronged approach that includes sustained veteran medical surveillance.

The Conventional Wisdom on PFAS Blood Testing Misses a Key Point

Conventional wisdom often suggests that PFAS blood testing is primarily useful for documenting exposure for legal purposes, but less so for guiding immediate medical treatment. I disagree with this assessment. While it’s true that there isn’t a specific drug to “cure” PFAS presence in the body, understanding a veteran’s PFAS blood levels can provide critical context for their overall health picture. A high PFAS concentration should absolutely trigger a more aggressive and proactive screening regimen for associated health conditions. For instance, if a veteran has elevated PFOA levels, their physician should be particularly vigilant about monitoring kidney function, thyroid hormones, and cholesterol levels. It’s about personalized preventative care. Knowing these levels allows clinicians to establish a baseline, identify veterans at higher risk, and potentially detect early signs of disease before they become advanced. It’s not about treating the PFAS itself, but about treating the increased risk it confers. This isn’t just about legal documentation. It’s about informed medical decision-making. The argument that blood testing offers limited clinical utility often overlooks its value in risk stratification and proactive surveillance. We shouldn’t discard a valuable piece of diagnostic information simply because there isn’t a direct antidote.

The long-term health monitoring of veterans exposed to PFAS requires a complete and sustained commitment, integrating expanded VA benefits, regular targeted medical screenings, and a clear understanding of individual risk profiles. Proactive engagement with the VA and ongoing medical vigilance are essential for working through the complex health challenges posed by these persistent chemicals. For more information on how the VA is handling healthcare changes, you might find our article on Oracle’s VA Health Overhaul insightful.